Coya Therapeutics, Inc. (COYA)
6.095
-0.04
(-0.73%)
USD |
NASDAQ |
Dec 10, 16:00
6.095
0.00 (0.00%)
After-Hours: 18:32
Coya Therapeutics Profit Margin (Quarterly): -59.36% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.72% |
| Electromed, Inc. | 12.65% |
| AbbVie, Inc. | 1.13% |
| Atea Pharmaceuticals, Inc. | -- |
| Picard Medical, Inc. | -878.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.41% |
| Return on Assets | -50.15% |
| Return on Invested Capital | -57.41% |
| Gross Profit Margin (Quarterly) | 99.81% |
| Operating Margin (Quarterly) | -53.78% |
| Return on Net Operating Assets | -455.1% |